Apatinib (Aitan) in patients with recurrent and metastatic intrahepatic cholangiocarcinoma: phase II clinical study
Latest Information Update: 03 Aug 2020
At a glance
- Drugs Rivoceranib (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 03 Aug 2020 New trial record